Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Association of serum bilirubin with contrast-induced nephropathy and future cardiovascular events in patients undergoing coronary intervention.

Huang SS, Huang PH, Wu TC, Chen JW, Lin SJ.

PLoS One. 2012;7(8):e42594. doi: 10.1371/journal.pone.0042594. Epub 2012 Aug 6.

2.

Association of central pulse pressure with contrast-induced nephropathy and clinical outcomes in patients undergoing coronary intervention.

Huang SS, Huang PH, Leu HB, Wu TC, Lin SJ, Chen JW.

J Hypertens. 2013 Nov;31(11):2187-94. doi: 10.1097/HJH.0b013e3283641023.

PMID:
23868087
3.

Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.

Barbieri L, Verdoia M, Schaffer A, Cassetti E, Marino P, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS)..

Nutr Metab Cardiovasc Dis. 2015 Feb;25(2):181-6. doi: 10.1016/j.numecd.2014.08.008. Epub 2014 Sep 19.

PMID:
25315668
4.

Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.

Kurtul A, Yarlioglues M, Murat SN, Demircelik MB, Acikgoz SK, Ergun G, Duran M, Cetin M, Ornek E.

Angiology. 2015 May;66(5):433-40. doi: 10.1177/0003319714535238. Epub 2014 May 16.

PMID:
24834929
5.

Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.

Capodanno D, Ministeri M, Cumbo S, Dalessandro V, Tamburino C.

Catheter Cardiovasc Interv. 2014 May 1;83(6):907-12. doi: 10.1002/ccd.25153. Epub 2013 Aug 31.

PMID:
23934631
6.

Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.

Kurtul A, Duran M, Yarlioglues M, Murat SN, Demircelik MB, Ergun G, Acikgoz SK, Sensoy B, Cetin M, Ornek E.

Clin Cardiol. 2014 Aug;37(8):485-92. doi: 10.1002/clc.22291. Epub 2014 May 7.

7.

Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.

Pyxaras SA, Sinagra G, Mangiacapra F, Perkan A, Di Serafino L, Vitrella G, Rakar S, De Vroey F, Santangelo S, Salvi A, Toth G, Bartunek J, De Bruyne B, Wijns W, Barbato E.

Am J Cardiol. 2013 Mar 1;111(5):684-8. doi: 10.1016/j.amjcard.2012.11.018. Epub 2012 Dec 19.

PMID:
23261003
8.

Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.

Oksuz F, Yarlioglues M, Cay S, Celik IE, Mendi MA, Kurtul A, Cankurt T, Kuyumcu S, Canpolat U, Turak O.

Am J Cardiol. 2015 Sep 1;116(5):711-6. doi: 10.1016/j.amjcard.2015.05.042. Epub 2015 Jun 4.

PMID:
26116992
9.

Reduction of circulating endothelial progenitor cell level is associated with contrast-induced nephropathy in patients undergoing percutaneous coronary and peripheral interventions.

Chiang CH, Huang PH, Chiu CC, Hsu CY, Leu HB, Huang CC, Chen JW, Lin SJ.

PLoS One. 2014 Mar 19;9(3):e89942. doi: 10.1371/journal.pone.0089942. eCollection 2014 Mar 19.

10.
11.

Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.

Barbieri L, Verdoia M, Schaffer A, Cassetti E, Di Giovine G, Marino P, Suryapranata H, De Luca G.

Diabetes Res Clin Pract. 2014 Dec;106(3):458-64. doi: 10.1016/j.diabres.2014.09.041. Epub 2014 Oct 6.

PMID:
25458324
12.

Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.

Li Y, Liu Y, Shi D, Yang L, Liang J, Zhou Y.

Angiology. 2016 Feb;67(2):139-45. doi: 10.1177/0003319715578997. Epub 2015 Apr 5.

PMID:
25843952
13.

Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.

Saritemur M, Turkeli M, Kalkan K, Tanboga İH, Aksakal E.

Am J Emerg Med. 2014 Feb;32(2):119-23. doi: 10.1016/j.ajem.2013.10.011. Epub 2013 Oct 11.

PMID:
24238488
14.

Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.

Ozturk D, Celik O, Erturk M, Kalkan AK, Uzun F, Akturk IF, Akin F, Yildirim A.

Can J Cardiol. 2016 Feb;32(2):240-6. doi: 10.1016/j.cjca.2015.05.005. Epub 2015 May 16.

PMID:
26255218
15.

Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Kume K, Yasuoka Y, Adachi H, Noda Y, Hattori S, Araki R, Kohama Y, Imanaka T, Matsutera R, Kosugi M, Sasaki T.

Cardiovasc Revasc Med. 2013 Sep-Oct;14(5):253-7. doi: 10.1016/j.carrev.2013.07.009. Epub 2013 Aug 28.

PMID:
23993293
16.

Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Börekçi A, Gür M, Türkoğlu C, Çaylı M, Selek Ş, Kaypaklı O, Uçar H, Coşkun M, Şeker T, Koç M, Gökdeniz T, Gözükara MY.

Angiology. 2015 Apr;66(4):339-45. doi: 10.1177/0003319714533588. Epub 2014 May 15.

PMID:
24830418
17.

Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.

An JN, Yoo KD, Hwang JH, Kim HL, Kim SH, Yang SH, Kim JH, Kim DK, Oh YK, Kim YS, Lim CS, Lee JP.

Nephrology (Carlton). 2015 Aug;20(8):552-9. doi: 10.1111/nep.12448.

PMID:
25783484
18.

The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.

Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.

Catheter Cardiovasc Interv. 2011 Aug 1;78(2):198-201. doi: 10.1002/ccd.22828. Epub 2010 Oct 14.

PMID:
20949583
19.

High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.

Liu Y, Tan N, Zhou YL, Chen YY, Chen JY, Chen J, Luo JF.

J Nephrol. 2012 May-Jun;25(3):332-40. doi: 10.5301/jn.5000007.

PMID:
21928234
20.

[Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].

He YT, Tan N, Liu YH, Chen SQ, Liu Y, Huang SJ, Yang DH, Ye P, Ran P.

Zhonghua Xin Xue Guan Bing Za Zhi. 2013 May;41(5):394-8. Chinese.

PMID:
24021122

Supplemental Content

Support Center